Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
J Neuroinflammation. 2024 Mar 23;21(1):71. doi: 10.1186/s12974-024-03047-1.
Cerebrospinal fluid (CSF) matrix biomarkers have become increasingly valuable surrogate markers of neuropsychiatric diseases in research and clinical practice. In contrast, CSF cells have been rarely investigated due to their relative scarcity and fragility, and lack of common collection and cryopreservation protocols, with limited exceptions for neurooncology and primary immune-based diseases like multiple sclerosis. the advent of a microfluidics-based multi-omics approach to studying individual cells has allowed for the study of cellular phenotyping, intracellular dynamics, and intercellular relationships that provide multidimensionality unable to be obtained through acellular fluid-phase analyses. challenges to cell-based research include site-to-site differences in handling, storage, and thawing methods, which can lead to inaccuracy and inter-assay variability. In the present study, we performed single-cell RNA sequencing (10x Genomics) on fresh or previously cryopreserved human CSF samples from three alternative cryopreservation methods: Fetal Bovine Serum with Dimethyl sulfoxide (FBS/DMSO), FBS/DMSO after a DNase step (a step often included in epigenetic studies), and cryopreservation using commercially available Recovery© media. In comparing relative differences between fresh and cryopreserved samples, we found little effect of the cryopreservation method on being able to resolve donor-linked cell type proportions, markers of cellular stress, and overall gene expression at the single-cell level, whereas donor-specific differences were readily discernable. We further demonstrate the compatibility of fresh and cryopreserved CSF immune cell sequencing using biologically relevant sexually dimorphic gene expression differences by donor. Our findings support the utility and interchangeability of FBS/DMSO and Recovery cryopreservation with fresh sample analysis, providing a methodological grounding that will enable researchers to further expand our understanding of the CSF immune cell contributions to neurological and psychiatric disease.
脑脊液(CSF)基质生物标志物已成为研究和临床实践中神经精神疾病的重要替代标志物。相比之下,由于 CSF 细胞数量相对较少且脆弱,加上缺乏通用的采集和冷冻保存方案,因此很少对其进行研究,神经肿瘤学和原发性免疫性疾病(如多发性硬化症)除外。基于微流控的多组学方法的出现使得研究单个细胞的细胞表型、细胞内动力学和细胞间关系成为可能,从而提供了无法通过无细胞液相比分析获得的多维性。基于细胞的研究面临的挑战包括在处理、存储和解冻方法方面的站点间差异,这可能导致不准确和试验间变异性。在本研究中,我们对来自三种不同冷冻保存方法的新鲜或先前冷冻保存的人 CSF 样本进行了单细胞 RNA 测序(10x Genomics):含二甲基亚砜的胎牛血清(FBS/DMSO)、经过 DNA 酶处理后的 FBS/DMSO(经常包含在表观遗传学研究中)和使用商业上可获得的 Recovery©介质进行冷冻保存。在比较新鲜和冷冻保存样本之间的相对差异时,我们发现冷冻保存方法对能够解析供体相关细胞类型比例、细胞应激标志物和单细胞水平的总体基因表达的影响很小,而供体特异性差异则很容易辨别。我们进一步证明了新鲜和冷冻 CSF 免疫细胞测序的兼容性,使用生物学上相关的性别二态性基因表达差异来区分供体。我们的研究结果支持 FBS/DMSO 和 Recovery 冷冻保存与新鲜样本分析的实用性和可互换性,为研究人员提供了一种方法基础,使他们能够进一步扩展我们对 CSF 免疫细胞对神经和精神疾病贡献的理解。
J Neuroinflammation. 2024-3-23
Biochem Biophys Res Commun. 2017-9-9
Cytotherapy. 2013-11
Biotechnol Lett. 2004-5
PLoS One. 2015-7-2
Nat Protoc. 2022-6
Cell. 2021-6-24
Mol Neurodegener. 2021-1-22
Fluids Barriers CNS. 2020-5-6